-
Signature
-
/s/ Thomas J. Wilson
-
Issuer symbol
-
ALL
-
Transactions as of
-
17 Nov 2025
-
Net transactions value
-
-$3,583,277
-
Form type
-
4
-
Filing time
-
19 Nov 2025, 16:09:25 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| WILSON THOMAS J |
Chairman, President & CEO, Director |
C/O THE ALLSTATE CORPORATION, 3100 SANDERS ROAD, NORTHBROOK |
/s/ Thomas J. Wilson |
19 Nov 2025 |
0001190466 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
ALL |
Common Stock |
Sale |
$3,275,591 |
-15,370 |
-8.6% |
$213.12 |
163,056 |
17 Nov 2025 |
Direct |
F1, F2 |
| transaction |
ALL |
Common Stock |
Sale |
$243,275 |
-1,137 |
-0.7% |
$213.96 |
161,919 |
17 Nov 2025 |
Direct |
F2, F3 |
| transaction |
ALL |
Common Stock |
Sale |
$64,411 |
-300 |
-0.19% |
$214.70 |
161,619 |
17 Nov 2025 |
Direct |
F2, F4 |
| holding |
ALL |
Common Stock |
|
|
|
|
|
111,442 |
17 Nov 2025 |
By 2023-B GRAT |
|
| holding |
ALL |
Common Stock |
|
|
|
|
|
65,321 |
17 Nov 2025 |
By 2024-C GRAT |
|
| holding |
ALL |
Common Stock |
|
|
|
|
|
69,822 |
17 Nov 2025 |
By 2025-A GRAT |
|
| holding |
ALL |
Common Stock |
|
|
|
|
|
7,643 |
17 Nov 2025 |
By 401(k) Plan |
|
| holding |
ALL |
Common Stock |
|
|
|
|
|
273,954 |
17 Nov 2025 |
By 2020 GRAT Remainder Trust |
|
| holding |
ALL |
Common Stock |
|
|
|
|
|
257,535 |
17 Nov 2025 |
Remainder GRAT |
|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: